Is idiopathic pulmonary fibrosis now treatable?

被引:9
作者
du Bois, RM [1 ]
机构
[1] Royal Brompton Hosp, London SW3 6LY, England
关键词
D O I
10.1164/rccm.2502001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:939 / 940
页数:2
相关论文
共 15 条
[1]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[2]   Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis [J].
Azuma, A ;
Nukiwa, T ;
Tsuboi, E ;
Suga, M ;
Abe, S ;
Nakata, K ;
Taguchi, Y ;
Nagai, S ;
Itoh, H ;
Ohi, M ;
Sato, A ;
Kudoh, S ;
Raghu, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (09) :1040-1047
[3]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[4]  
DAVIES HR, 2004, COCHRANE LIB
[5]   Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis [J].
Fellrath, JM ;
du Bois, RM .
CLINICAL AND EXPERIMENTAL MEDICINE, 2003, 3 (02) :65-83
[6]   Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia [J].
Flaherty, KR ;
Mumford, JA ;
Murray, S ;
Kazerooni, EA ;
Gross, BH ;
Colby, TV ;
Travis, WD ;
Flint, A ;
Toews, GB ;
Lynch, JP ;
Martinez, FJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :543-548
[7]   Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis [J].
King, TE ;
Safrin, S ;
Starko, KM ;
Brown, KK ;
Noble, PW ;
Raghu, G ;
Schwartz, DA .
CHEST, 2005, 127 (01) :171-177
[8]   Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia [J].
Lama, VN ;
Flaherty, KR ;
Toews, GB ;
Colby, TV ;
Travis, WD ;
Long, Q ;
Murray, S ;
Kazerooni, EA ;
Gross, BH ;
Lynch, JP ;
Martinez, FJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (09) :1084-1090
[9]   Fibrotic idiopathic interstitial pneumonia - The prognostic value of longitudinal functional trends [J].
Latsi, PI ;
du Bois, RM ;
Nicholson, AG ;
Colby, TV ;
Bisirtzoglou, D ;
Nikolakopoulou, A ;
Veeraraghavan, S ;
Hansell, DM ;
Wells, AU .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :531-537
[10]   A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis [J].
Raghu, G ;
Brown, KK ;
Bradford, WZ ;
Starko, K ;
Noble, PW ;
Schwartz, DA ;
King, TE ;
Adlakha, A ;
Tarczynski, S ;
Ainslie, G ;
Kalam, R ;
Bai, T ;
Truchan, H ;
Baughman, R ;
Wingst, D ;
Bhorade, S ;
Norwick, L ;
Brown, KK ;
Kervitsky, D ;
Calhoun, W ;
DiNella, L ;
Chan, C ;
Jamieson, L ;
Chan, K ;
Turpen, T ;
Chapman, J ;
Slattery, S ;
Chen, L ;
Turner, J ;
Clark, M ;
Sanders, R ;
Crain, M ;
Pate, D ;
Davis, G ;
Lynn, M ;
Dhar, A ;
Hrytsytk, M ;
Drent, M ;
Horr, ET ;
du Bois, R ;
Goh, N ;
Egan, J ;
Anthony, N ;
Enelow, R ;
Haram, T ;
Ettinger, N ;
Merli, S ;
Frost, A ;
Holy, R ;
Glassberg, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (02) :125-133